GNAQ and cardiomyopathy: Loss of FHL1 is advantageous in cardiomyopathy caused by Gαq overexpression (Sheikh et al. 2008), but deleterious in the MHC403/+ model of hypertrophic cardiomyopathy (Christodoulou et al. 2014).